Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Hartung

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Health Affairs (Project Hope)|September 13, 2006
An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug PlanDaniel M Hartung, Kathy L Ketchum, Dean G Haxby
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Obstetrics and Gynecology|May 29, 2019
Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid PopulationLorinda Anderson, Daniel M Hartung, Luke Middleton, et al.
Substance Abuse|December 20, 2015
A chronic opioid therapy dose reduction policy in primary careMelissa B Weimer, Daniel M Hartung, Sharia Ahmed, et al.
Diabetes Care|February 12, 2020
Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part DChien-Wen Tseng, Camlyn Masuda, Randi Chen, et al.
Journal of the American Board of Family Medicine : JABFM|May 10, 2013
Breaking up is hard to do: lessons learned from a pharma-free practice transformationDavid Evans, Daniel M Hartung, Denise Beasley, et al.
CNS Drugs|June 27, 2012
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover studyDaniel M Hartung, Luke Middleton, Leanne Svoboda, et al.
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Health Affairs (Project Hope)|September 13, 2006
An evaluation of Oregon's evidence-based Practitioner-Managed Prescription Drug PlanDaniel M Hartung, Kathy L Ketchum, Dean G Haxby
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Obstetrics and Gynecology|May 29, 2019
Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid PopulationLorinda Anderson, Daniel M Hartung, Luke Middleton, et al.
Substance Abuse|December 20, 2015
A chronic opioid therapy dose reduction policy in primary careMelissa B Weimer, Daniel M Hartung, Sharia Ahmed, et al.
Diabetes Care|February 12, 2020
Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part DChien-Wen Tseng, Camlyn Masuda, Randi Chen, et al.
Journal of the American Board of Family Medicine : JABFM|May 10, 2013
Breaking up is hard to do: lessons learned from a pharma-free practice transformationDavid Evans, Daniel M Hartung, Denise Beasley, et al.
CNS Drugs|June 27, 2012
Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover studyDaniel M Hartung, Luke Middleton, Leanne Svoboda, et al.
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Pageof 11